{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:42:43Z","timestamp":1791214963471,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.joms.2016.01.022","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T11:44:11Z","timestamp":1453376651000},"page":"1120-1130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Role of Collagen Conduit With Duloxetine and\/or Pregabalin in the Management of Partial Peripheral Nerve Injury"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3107-6118","authenticated-orcid":false,"given":"Junad","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Moin","family":"Anwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Eliav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ziccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2016.01.022_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2010.07.031","article-title":"NeuPSIG guidelines on neuropathic pain assessment","volume":"152","author":"Haanpaa","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.joms.2016.01.022_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.expneurol.2009.09.009","article-title":"Current applications and future perspectives of artificial nerve conduits","volume":"223","author":"Jiang","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.joms.2016.01.022_bib3","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1093\/brain\/awl296","article-title":"The cellular inflammatory response in human spinal cords after injury","volume":"129","author":"Fleming","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.joms.2016.01.022_bib4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.joms.2011.03.054","article-title":"Is there a role for a collagen conduit and anti-inflammatory agent in the management of partial peripheral nerve injuries?","volume":"71","author":"Shanti","year":"2013","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.01.022_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1472-6750-8-39","article-title":"Electrospun micro- and nanofiber tubes for functional nervous regeneration in sciatic nerve transections","volume":"8","author":"Panseri","year":"2008","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.joms.2016.01.022_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1061-3315(18)30013-1","article-title":"Mechanisms of trigeminal nerve injuries","volume":"9","author":"Ziccardi","year":"2001","journal-title":"Atlas Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.joms.2016.01.022_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/joms.2001.22671","article-title":"Use of Gore-Tex tubing as a conduit for inferior alveolar and lingual nerve repair: Experience with 6 cases","volume":"59","author":"Pitta","year":"2001","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.01.022_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0278-2391(98)90107-0","article-title":"Gore-Tex tubing as a conduit for repair of lingual and inferior alveolar nerve continuity defects: A preliminary report","volume":"56","author":"Pogrel","year":"1998","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.01.022_bib9","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.2106\/JBJS.H.01301","article-title":"Treatment of a segmental nerve defect in the rat with use of bioabsorbable synthetic nerve conduits: A comparison of commercially available conduits","volume":"91","author":"Shin","year":"2009","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.joms.2016.01.022_bib10","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.joms.2008.06.017","article-title":"A bioabsorbable collagen nerve cuff (NeuraGen) for repair of lingual and inferior alveolar nerve injuries: A case series","volume":"66","author":"Farole","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.01.022_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cne.903060410","article-title":"A collagen-based nerve guide conduit for peripheral nerve repair: An electrophysiological study of nerve regeneration in rodents and nonhuman primates","volume":"306","author":"Archibald","year":"1991","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.joms.2016.01.022_bib12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/SAP.0b013e31804d441c","article-title":"US Food and Drug Administration\/Conformit Europe-approved absorbable nerve conduits for clinical repair of peripheral and cranial nerves","volume":"60","author":"Meek","year":"2008","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.joms.2016.01.022_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1601-0825.2011.01883.x","article-title":"Peripheral painful traumatic trigeminal neuropathies","volume":"18","author":"Benoliel","year":"2012","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2016.01.022_bib14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"European Federation of Neurological Societies, EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.joms.2016.01.022_bib15","unstructured":"US Food and Drug Administration: FDA approves first drug for treating fibromyalgia. Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2007\/ucm108936.htm. Published April 26,\u00a02010. Accessed February 12, 2016"},{"key":"10.1016\/j.joms.2016.01.022_bib16","unstructured":"Pfizer Pharmaceuticals: Lyrica prescribing information. Available at: http:\/\/www.fda.gov\/cder. Published April 26,\u00a02010. Accessed February 12, 2016"},{"key":"10.1016\/j.joms.2016.01.022_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00002508-200503000-00003","article-title":"Differential effects of neuropathic analgesics on wind-up-like pain and somatosensory function in healthy volunteers","volume":"21","author":"Harding","year":"2005","journal-title":"Clin J Pain"},{"key":"10.1016\/j.joms.2016.01.022_bib18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/MJT.0b013e3181df8e1b","article-title":"Fibromyalgia syndrome: A discussion of the syndrome and pharmacotherapy","volume":"17","author":"Smith","year":"2010","journal-title":"Am J Ther"},{"key":"10.1016\/j.joms.2016.01.022_bib19","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","article-title":"SNRIs: Their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.joms.2016.01.022_bib20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/papr.12009","article-title":"Duloxetine and pregabalin for pain management in multiple rheumatic diseases associated with fibromyalgia","volume":"13","author":"Angeletti","year":"2013","journal-title":"Pain Pract"},{"key":"10.1016\/j.joms.2016.01.022_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004714-200104000-00012","article-title":"Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma\/interleukin-10 production ratio","volume":"21","author":"Kubera","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.joms.2016.01.022_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","article-title":"Interleukin-10: New perspectives on an old cytokine","volume":"226","author":"Mosser","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.joms.2016.01.022_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11481-012-9428-2","article-title":"Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain","volume":"8","author":"Sacerdote","year":"2013","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.joms.2016.01.022_bib24","first-page":"803","article-title":"Neuropathic pain and cytokines: Current perspectives","volume":"6","author":"Clark","year":"2013","journal-title":"J Pain Res"},{"key":"10.1016\/j.joms.2016.01.022_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.joms.2016.01.022_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1124\/jpet.104.070656","article-title":"Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats","volume":"311","author":"Iyengar","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.joms.2016.01.022_bib27","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/00000542-200112000-00029","article-title":"Stereospecific effect of pregabalin on ectopic afferent discharges and neuropathic pain induced by sciatic nerve ligation in rats","volume":"95","author":"Chen","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.joms.2016.01.022_bib28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s11596-012-1001-y","article-title":"Pregabalin attenuates docetaxel-induced neuropathy in rats","volume":"32","author":"Peng","year":"2012","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.joms.2016.01.022_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3959(00)00354-7","article-title":"Partial sciatic nerve transection as a model of neuropathic pain: A qualitative and quantitative neuropathological study","volume":"89","author":"Lindenlaub","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.joms.2016.01.022_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2015.03.001","article-title":"Interleukin-10 levels in rat models of nerve damage and neuropathic pain","volume":"592","author":"Khan","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.joms.2016.01.022_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2011.01.079","article-title":"Interleukin-17 levels in rat models of nerve damage and neuropathic pain","volume":"493","author":"Noma","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.joms.2016.01.022_bib32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1358\/mf.2007.29.7.1074689","article-title":"Evaluation of ketamine, nimodipine, gabapentin and imipramine in partial sciatic nerve transection model of neuropathic pain in rat: An experimental study","volume":"29","author":"Hota","year":"2007","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.joms.2016.01.022_bib33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0304-3959(94)90013-2","article-title":"Extra-territorial pain in rats with a peripheral mononeuropathy: Mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve","volume":"57","author":"Tal","year":"1994","journal-title":"Pain"},{"key":"10.1016\/j.joms.2016.01.022_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.joms.2016.01.022_bib35","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bbi.2009.01.012","article-title":"The role of IL-6 and IL-1beta in painful perineural inflammatory neuritis","volume":"23","author":"Eliav","year":"2009","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.joms.2016.01.022_bib36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3959(99)00102-5","article-title":"Neuropathic pain from an experimental neuritis of the rat sciatic nerve","volume":"83","author":"Eliav","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.joms.2016.01.022_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.joms.2016.01.022_bib38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.joms.2016.01.022_bib39","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1128\/IAI.66.11.5224-5231.1998","article-title":"Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice","volume":"66","author":"Sellon","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.joms.2016.01.022_bib40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1359-6101(02)00025-4","article-title":"The role of interleukin-10 in autoimmune disease: Systemic lupus erythematosus (SLE) and multiple sclerosis (MS)","volume":"13","author":"Beebe","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.joms.2016.01.022_bib41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2249.1996.tb08288.x","article-title":"Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA)","volume":"103","author":"Bucht","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.joms.2016.01.022_bib42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s000110050042","article-title":"1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells","volume":"46","author":"Michel","year":"1997","journal-title":"Inflamm Res"},{"key":"10.1016\/j.joms.2016.01.022_bib43","first-page":"267","article-title":"High levels of TH2 cytokine gene expression in systemic lupus erythematosus","volume":"47","author":"Richaud-Patin","year":"1995","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.joms.2016.01.022_bib44","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s11095-010-0077-y","article-title":"Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration","volume":"27","author":"Soderquist","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.joms.2016.01.022_bib45","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nrd1251","article-title":"Glia: A novel drug discovery target for clinical pain","volume":"2","author":"Watkins","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.joms.2016.01.022_bib46","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1002\/eji.200737625","article-title":"IL-10 modulates cytokine gene transcription by protein synthesis-independent and dependent mechanisms in lipopolysaccharide-treated neutrophils","volume":"37","author":"Rossato","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.joms.2016.01.022_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jneuroim.2010.08.013","article-title":"The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines","volume":"229","author":"Austin","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.joms.2016.01.022_bib48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2013.01.072","article-title":"Importance of glial activation in neuropathic pain","volume":"716","author":"Mika","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.joms.2016.01.022_bib49","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1523\/JNEUROSCI.23-07-02517.2003","article-title":"Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons","volume":"23","author":"Schafers","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.joms.2016.01.022_bib50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brainresrev.2005.11.004","article-title":"Immune and inflammatory mechanisms in neuropathic pain","volume":"51","author":"Moalem","year":"2006","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.joms.2016.01.022_bib51","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/jir.1996.16.695","article-title":"Interleukin-6-mediated hyperalgesia\/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model","volume":"16","author":"DeLeo","year":"1996","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.joms.2016.01.022_bib52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3959(98)00121-3","article-title":"Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice","volume":"78","author":"Ramer","year":"1998","journal-title":"Pain"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239116001142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239116001142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:48:50Z","timestamp":1759510130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239116001142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0278239116001142"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2016.01.022","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Collagen Conduit With Duloxetine and\/or Pregabalin in the Management of Partial Peripheral Nerve Injury","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2016.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Association of Oral and Maxillofacial Surgeons","name":"copyright","label":"Copyright"}]}}